Vipin Garg

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -10% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
President, Chief Executive Officer, Director Neos Therapeutics Inc Oct. 1, 2013 - June 27, 2018
President, Chief Executive Officer, Director Ocera Therapeutics Inc Oct. 1, 2000 - July 15, 2013
Vipin Garg's trades of Altimmune Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
333.60
Quantity 5,245 -16.6%
Value US$2,868,396
Transaction date
Planned sale
Price
34.36
Quantity 21,900 +4.5%
Value US$2,150,104
Transaction date
Purchase
Price
396.83
Quantity 33,637 +36.3%
Value US$1,024,448
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-09-01 2022-08-31
PlS Planned sale
5,245 -16.6%
333.60
US$2,868,396 		5,245 -16.6% 333.60 US$2,868,396
2022-08-12 2022-08-12
PlS Planned sale
21,900 +4.5%
34.36
US$2,150,104 		21,900 +4.5% 34.36 US$2,150,104
2019-09-05 2019-09-05
B Purchase
33,637 +36.3%
396.83
US$1,024,448 		33,637 +36.3% 396.83 US$1,024,448